Search Medical Condition
Please enter condition
Please choose location

Liver Disease Clinical Trials

A listing of Liver Disease medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (337) clinical trials

To explore the antiviral efficacy of combination therapy with sofosbuvir/ledipasvir fixed-dose combination ribavirin for 12 or 24 weeks in patients with advanced liver disease. Study designed with A cohort and B cohort.

Phase N/A

What is Alpha-1 Antitrypsin Deficiency? Alpha-1 Antitrypsin Deficiency is a genetic (inherited) condition that may result in serious lung disease in adults and/or liver disease at any age. Alpha-1 Antitrypsin Deficiency occurs when there is a lack of a protein in the blood called alpha-1 antitrypsin, or AAT. AAT is ...

Phase N/A

Nonalcoholic steatohepatitis (NASH) is liver inflammation caused by a buildup of fat in the liver. ClinSearch is enrolling volunteers in a study of an investigational medication for people with decompensated cirrhosis from NASH.

Phase N/A

To explore the antiviral efficacy of combination therapy with sofosbuvir/ledipasvir fixed-dose combination ribavirin for 12 or 24 weeks in patients with advanced liver disease. Study designed with A cohort and B cohort.

Phase N/A

The Cohera Sylys® Surgical Sealant study is a prospective, randomized, controlled, multicenter technical feasibility clinical study comparing standard anastomosis closure technique (Control) to standard closure techniques plus Sylys® Surgical Sealant (Test) during colorectal and ileorectal anastomosis procedures.

Phase N/A

A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Study Evaluating the Safety and Efficacy of Obeticholic Acid (study medication) in Subjects with Nonalcoholic Steatohepatitis (NASH).

Phase

A Randomized, Double-Blind, Parallel-Group Dose-Ranging Study to Evaluate the Safety and Efficacy of NI-03 (Study Medication) compared to Placebo in Subjects with Chronic Pancreatitis.

Phase N/A

Clinical Trials of Texas, Inc. is conducting a research study of an investigational medication for patients with non-alcoholic fatty liver disease accompanied by high cholesterol. Non-alcoholic Fatty Liver disease doesn’t usually have symptoms, but you may be at risk if you are overweight and fatigued. Qualified participants receive study-related medical ...

Phase N/A

A research study is evaluating an investigational medication for NASH (Nonalcoholic steatohepatitis), a type of Nonalcoholic Fatty Liver Disease. This research study may be an option if you: Have liver biopsy results showing evidence of NASH Do not have any other liver conditions (such as but not limited to: hepatitis ...

Phase N/A

A randomized, double-blind, placebo-controlled phase III study of regorafenib plus best supportive care versus placebo plus best supportive care for subjects with metastatic and/or unresectable gastrointestinal stromal tumors (GIST) whose disease has progressed despite prior treatment with at least imatinib and sunitinib. The study is composed of 3 periods: A ...

Phase